Article ID Journal Published Year Pages File Type
8940765 European Urology Oncology 2018 16 Pages PDF
Abstract
Two ways to potentially improve outcomes following salvage radiotherapy for prostate cancer that recurs after prostatectomy are to start treatment at a lower prostate-specific antigen level and to use concurrent hormonal therapy. Our review suggests that the available evidence is imperfect, but highlights that both measures are likely to improve clinical outcomes in general, but perhaps not uniformly and/or consistently for all patients. Physician-patient shared decision-making and further research are critical.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , ,